These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current theories on the hepatorenal syndrome]. Mysliwiec M; Myśliwiec B Przegl Lek; 1983; 40(9):689-92. PubMed ID: 6364259 [No Abstract] [Full Text] [Related]
3. [Changes in renal function and the intracellular environment in cirrhotic patients]. Tiberio López G; Tanco S; Orradre B; Berrade MF; Anderiz López M Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):367-78. PubMed ID: 2988084 [No Abstract] [Full Text] [Related]
4. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Gentilini P; Laffi G; La Villa G; Raggi VC Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of the hepatorenal syndrome. Laffi G; La Villa G; Gentilini P Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664 [No Abstract] [Full Text] [Related]
17. The hepatorenal syndrome (HRS). Epstein M Adv Exp Med Biol; 1987; 212():157-65. PubMed ID: 3303848 [No Abstract] [Full Text] [Related]
18. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. Epstein M J Am Soc Nephrol; 1994 Apr; 4(10):1735-53. PubMed ID: 8068872 [TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid derivatives and renal function in liver cirrhosis. Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864 [TBL] [Abstract][Full Text] [Related]